EMEA-001949-PIP01-16-M04
Key facts
Active substance |
Gadopiclenol
|
Therapeutic area |
Diagnostic
|
Decision number |
P/0152/2021
|
PIP number |
EMEA-001949-PIP01-16-M04
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
Detection and visualisation of areas with disruption of the blood brain barrier and/or abnormal vascularity for diagnostic purposes
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
Guerbet
Tel. +33 145915076 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|